Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06331364

TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): a Stepped-Wedge Cluster Randomized Trial

TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): A Stepped-wedge Cluster Randomized Trial of an Electronic Clinical Decision Support Tool (eCDST) for the Diagnosis and Treatment of Lower Respiratory Tract Infection (LRTI) in Selected Hospitals in Southern Sri Lanka

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
765 (estimated)
Sponsor
Duke University · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

This is a stepped-wedge, cluster-randomized, two-arm, open-label, clinical trial of an electronic clinical decision support tool (eCDST) for the diagnosis and treatment of lower respiratory tract infection (LRTI) among patients at three sites in Southern Province, Sri Lanka. The primary objective of this trial is to determine the impact of an electronic clinical decision support tool (eCDST) on clinical outcomes and antibacterial prescription in subjects with LRTI in the intervention group compared to the control group. The study will enroll 765 patients ≥ 14 years of age. Medical wards will be randomized in clusters to the intervention at intervals of 3-6 months until all clusters cross over. Participants will be followed for 30 days from enrollment to record clinical outcomes and any antimicrobials prescribed (a maximum of 14 days).

Conditions

Interventions

TypeNameDescription
OTHERelectronic clinical decision support tool (eCDST) diagnostic planParticipants will be followed for 30 days from enrollment to record clinical outcomes and any antimicrobials used. Analyses will compare clinical outcomes and antimicrobial use between the intervention arm and usual care.

Timeline

Start date
2026-02-27
Primary completion
2027-02-01
Completion
2028-02-01
First posted
2024-03-26
Last updated
2026-03-16

Locations

3 sites across 1 country: Sri Lanka

Source: ClinicalTrials.gov record NCT06331364. Inclusion in this directory is not an endorsement.